Evidence map›Paper›PMID 37887262›Full record

ArticleMedicines (Basel, Switzerland)2023

Monoclonal Gammopathy of Renal Significance with Deposits of Infrequent Morphology: Two Case Reports of Light and Heavy Chain Deposition Disease with Atypical Presentation and Literature Review.

José C De La Flor, Maribel Monroy-Condori, Jacqueline Apaza-Chavez, Iván Arenas-Moncaleano, Francisco Díaz, Xavier E Guerra-Torres, Jorge L Morales-Montoya, Ana Lerma-Verdejo, Edna Sandoval, Daniel Villa and 1 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Medicines (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

José C De La FlorDepartment of Nephrology, Hospital Central de la Defensa, 28046 Madrid, Spain.ORCID 0000-0001-9346-2279
Maribel Monroy-CondoriSection of Nephrology and Hypertension, Hospital General Universitario Nuestra Señora del Prado, 45600 Talavera de la Reina, Spain.
Jacqueline Apaza-ChavezDepartment of Nephrology, Hospital Fuensanta, 28027 Madrid, Spain.
Iván Arenas-MoncaleanoSection of Nephrology and Hypertension, Hospital General Universitario Nuestra Señora del Prado, 45600 Talavera de la Reina, Spain.
Francisco DíazDepartment of Anatomic Pathology, Hospital Gregorio Marañón, 28007 Madrid, Spain.ORCID 0000-0001-5090-8488
Xavier E Guerra-TorresSection of Nephrology and Hypertension, Hospital General Universitario Nuestra Señora del Prado, 45600 Talavera de la Reina, Spain.
Jorge L Morales-MontoyaSection of Nephrology and Hypertension, Hospital General Universitario Nuestra Señora del Prado, 45600 Talavera de la Reina, Spain.
Ana Lerma-VerdejoDepartment of Hematology, Hospital General Nuestra Señora del Prado, 45600 Talavera de la Reina, Spain.
Edna SandovalDepartment of Hematology, Hospital Central de la Defensa, 28046 Madrid, Spain.
Daniel VillaDepartment of Nephrology, Hospital Clínica Universiad Navarra, 31009 Pamplona, Spain.ORCID 0000-0001-8982-8442
Coca-Mihaela VieruDepartment of Anatomic Pathology, Hospital Gregorio Marañón, 28007 Madrid, Spain.
Hospital General Nuestra Señora del Prado · ESHospital Central de la Defensa Gómez Ulla · ESHospital General Universitario Gregorio Marañón · ESClinica Universidad de Navarra · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMonoclonal immunoglobulin deposition disease (MIDD) includes three entities: light chain deposition disease (LCDD), heavy chain deposition disease (HCDD) and light and heavy chain deposition disease (LHCDD). The renal presentation can manifest with varying degrees of proteinuria and/or nephrotic syndrome, microhematuria, and often leads to end-stage renal disease. Given the rarity of LHCDD, therapeutic approaches for this condition remain inconclusive, as clinical trials are limited. CASE PRESENTATION: We report two male patients with underlying monoclonal gammopathy of renal significance (MGRS) associated with LHCDD lesions. Both cases had non-nephrotic proteinuria, moderately impaired renal function, and normal levels of C3 and C4. Light microscopy of the renal biopsies in both patients did not show lesions of nodular glomerulosclerosis. Immunofluorescence showed a staining pattern with interrupted linear IgA-κ in patient #1 and IgA-λ in patient #2 only along the glomerular basement membrane (GBM). Electron microscopy of patient #1 revealed electrodense deposits in the subendothelial and mesangial areas only along the GBM. DISCUSSION: In this case series, we discuss the clinical, analytical, and histopathological findings of two rare cases of LHCDD. Both patients exhibited IgA monoclonality and were diagnosed with monoclonal gammopathy of undetermined significance (MGUS) by the hematology department at the time of renal biopsy. Treatment with steroids and cytotoxic agents targeting the clone cells responsible for the deposition disease resulted in a favorable renal and hematologic response.

Indexed as

light and heavy chain deposition diseasemonoclonal gammopathy of renal significancemonoclonal immunoglobulin deposits disease

Identifiers

PMID37887262
PMCPMC10608252
OpenAlexW4387343974

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.